114 related articles for article (PubMed ID: 19644934)
1. A computationally inspired investigation of the solid forms of (R)-1-phenylethylammonium-(S)-2-phenylbutyrate.
Antoniadis CD; D'Oria E; Karamertzanis PG; Tocher DA; Florence AJ; Price SL; Jones AG
Chirality; 2010 May; 22(4):447-55. PubMed ID: 19644934
[TBL] [Abstract][Full Text] [Related]
2. Toward the computational design of diastereomeric resolving agents: an experimental and computational study of 1-phenylethylammonium-2-phenylacetate derivatives.
Karamertzanis PG; Anandamanoharan PR; Fernandes P; Cains PW; Vickers M; Tocher DA; Florence AJ; Price SL
J Phys Chem B; 2007 May; 111(19):5326-36. PubMed ID: 17441754
[TBL] [Abstract][Full Text] [Related]
3. Solid-state forms of sodium valproate, active component of the anticonvulsant drug epilim.
Petrusevski G; Naumov P; Jovanovski G; Bogoeva-Gaceva G; Ng SW
ChemMedChem; 2008 Sep; 3(9):1377-86. PubMed ID: 18613204
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular structures of 1-phenylethylammonium tartrates.
Turkington DE; MacLean EJ; Lough AJ; Ferguson G; Glidewell C
Acta Crystallogr B; 2005 Feb; 61(Pt 1):103-14. PubMed ID: 15659863
[TBL] [Abstract][Full Text] [Related]
5. From crystal structure prediction to polymorph prediction: interpreting the crystal energy landscape.
Price SL
Phys Chem Chem Phys; 2008 Apr; 10(15):1996-2009. PubMed ID: 18688351
[TBL] [Abstract][Full Text] [Related]
6. Challenges of crystal structure prediction of diastereomeric salt pairs.
Karamertzanis PG; Price SL
J Phys Chem B; 2005 Sep; 109(36):17134-50. PubMed ID: 16853186
[TBL] [Abstract][Full Text] [Related]
7. In situ high-pressure crystallization and compression of halogen contacts in dichloromethane.
Podsiadło M; Dziubek K; Katrusiak A
Acta Crystallogr B; 2005 Oct; 61(Pt 5):595-600. PubMed ID: 16186660
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition and crystal energy landscapes: an X-ray and computational study of caffeine and other methylxanthines.
Carlucci L; Gavezzotti A
Chemistry; 2004 Dec; 11(1):271-9. PubMed ID: 15551321
[TBL] [Abstract][Full Text] [Related]
9. Erasing conformational limitations in N,N'-1,4-butanediyl-bis(6-hydroxy-hexanamide) crystallization from the superheated state of water.
Harings JA; Yao Y; Graf R; van Asselen O; Broos R; Rastogi S
Langmuir; 2009 Jul; 25(13):7652-66. PubMed ID: 19374343
[TBL] [Abstract][Full Text] [Related]
10. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
Braun DE; Vickers M; Griesser UJ
Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
[TBL] [Abstract][Full Text] [Related]
11. Solvent-induced chirality control in the enantioseparation of 1-phenylethylamine via diastereomeric salt formation.
Kodama K; Kimura Y; Shitara H; Yasutake M; Sakurai R; Hirose T
Chirality; 2011 Apr; 23(4):326-32. PubMed ID: 21384437
[TBL] [Abstract][Full Text] [Related]
12. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
13. Conformational, concomitant polymorphs of 4,4-diphenyl-2,5-cyclohexadienone: conformation and lattice energy compensation in the kinetic and thermodynamic forms.
Roy S; Banerjee R; Nangia A; Kruger GJ
Chemistry; 2006 May; 12(14):3777-88. PubMed ID: 16514685
[TBL] [Abstract][Full Text] [Related]
14. Characterization of complicated new polymorphs of chlorothalonil by X-ray diffraction and computer crystal structure prediction.
Tremayne M; Grice L; Pyatt JC; Seaton CC; Kariuki BM; Tsui HH; Price SL; Cherryman JC
J Am Chem Soc; 2004 Jun; 126(22):7071-81. PubMed ID: 15174878
[TBL] [Abstract][Full Text] [Related]
15. Polymorphs of 1,1-bis(4-hydroxyphenyl)cyclohexane and multiple Z' crystal structures by melt and sublimation crystallization.
Sarma B; Roy S; Nangia A
Chem Commun (Camb); 2006 Dec; (47):4918-20. PubMed ID: 17136246
[TBL] [Abstract][Full Text] [Related]
16. Use of an ion-binding site to bypass the 1000-atom limit to structure determination by direct methods.
Mooers BH; Matthews BW
Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1726-37. PubMed ID: 15388918
[TBL] [Abstract][Full Text] [Related]
17. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR.
Gonnella NC; Smoliga JA; Campbell S; Busacca CA; Cerreta M; Varsolona R; Norwood DL
J Pharm Biomed Anal; 2010 Apr; 51(5):1047-53. PubMed ID: 20018474
[TBL] [Abstract][Full Text] [Related]
18. Determination of trace amounts of β tegafur in commercial α tegafur by powder X-ray diffractometric analysis.
Petkune S; Bobrovs R; Actiņš A
J Pharm Pharmacol; 2011 Sep; 63(9):1136-40. PubMed ID: 21827485
[TBL] [Abstract][Full Text] [Related]
19. Crystalline polymorphism and molecular structure of sodium pravastatin.
Martín-Islan AP; Cruzado MC; Asensio R; Sainz-Díaz CI
J Phys Chem B; 2006 Dec; 110(51):26148-59. PubMed ID: 17181270
[TBL] [Abstract][Full Text] [Related]
20. Kinetic insights into the role of the solvent in the polymorphism of 5-fluorouracil from molecular dynamics simulations.
Hamad S; Moon C; Catlow CR; Hulme AT; Price SL
J Phys Chem B; 2006 Feb; 110(7):3323-9. PubMed ID: 16494346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
